MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,000 | -63.6% | 24 | -65.7% | 0.00% | -50.0% |
| Q2 2021 | $11,000 | -26.7% | 70 | -18.6% | 0.00% | -33.3% |
| Q1 2021 | $15,000 | -25.0% | 86 | -6.5% | 0.00% | -40.0% |
| Q4 2020 | $20,000 | -33.3% | 92 | -48.6% | 0.01% | -37.5% |
| Q3 2020 | $30,000 | -6.2% | 179 | -36.7% | 0.01% | -20.0% |
| Q2 2020 | $32,000 | +45.5% | 283 | 0.0% | 0.01% | +11.1% |
| Q1 2020 | $22,000 | -15.4% | 283 | +38.0% | 0.01% | +28.6% |
| Q4 2019 | $26,000 | +52.9% | 205 | -8.5% | 0.01% | -12.5% |
| Q3 2019 | $17,000 | -19.0% | 224 | +11.4% | 0.01% | -11.1% |
| Q2 2019 | $21,000 | – | 201 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |